SS Innovations International (SSII) Research & Development (2016 - 2026)
SS Innovations International (SSII) reported Research & Development of $995440.0 for Q1 2026, down 1.45% on a YoY basis from $1.0 million in Q1 2025, and down 28.43% sequentially from $1.4 million in Q4 2025.
SS Innovations International (SSII) Research & Development (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Research & Development data on file, last reported at $995440.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 1.45% year-over-year to $995440.0; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (up 23.45% YoY), and the FY2025 full-year result was $3.7 million, up 47.92% from the prior year.
- Research & Development eased to $995440.0 in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.4 million in Q4 2025 to a low of $31037.0 in Q4 2022.
- A 5-year average of $547290.2 and a median of $470719.5 in 2024 frame the typical range for Research & Development.
- Across the five-year window, Research & Development soared 33640.7% in 2022 and sank 34.31% in 2025, its largest moves.
- Tracing SSII's Research & Development over 5 years: stood at $31037.0 in 2022, then surged by 796.34% to $278198.0 in 2023, then soared by 173.88% to $761937.0 in 2024, then soared by 82.54% to $1.4 million in 2025, then declined by 28.43% to $995440.0 in 2026.
- Business Quant data shows SSII's Research & Development at $995440.0 in Q1 2026, $1.4 million in Q4 2025, and $786319.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 995,440.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 995,440.00 |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 786,319.00 |
| Jun 30, 2025 | 498,600.00 |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 761,937.00 |
| Sep 30, 2024 | 442,839.00 |
| Jun 30, 2024 | 759,004.00 |
| Mar 31, 2024 | 527,991.00 |
| Dec 31, 2023 | 278,198.00 |
| Sep 30, 2023 | 291,909.00 |
| Jun 30, 2023 | 246,426.00 |
| Mar 31, 2023 | 242,127.00 |
| Dec 31, 2022 | 31,037.00 |
| Sep 30, 2022 | 156,489.00 |
| Jun 30, 2022 | 337,407.00 |
| Jun 30, 2021 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 4,500.00 |